Trends in Infectious Diseases

Updates on Treatment & Prevention Strategies for HIV and HCV

Catch up with experts on the latest evidence related to HIV prevention, rapid-start antiretroviral (ART) therapy, and HCV screening and treatment for people who inject drugs—the population at highest risk of transmission. These 15-minute expert interviews will provide the epidemiologic trends that underlie the imperative for HIV preexposure prophylaxis (PrEP), present HIV treatment as prevention (TasP), and emphasize the feasibility, efficacy, and ease of treating HCV-infected PWID.

This activity is jointly provided by Global Education Group and Integritas Communications.

 

Supported by an educational grant from Gilead Sciences, Inc.

Image Webcast
Trends in Infectious Diseases: Updates on Treatment & Prevention Strategies for HIV and HCV

HIV Can Be Prevented— Are You Doing Your Part?

Isolde Butler, MD, MPH; Charlene A. Flash, MD, MPH
MODULE 1
Begin Activity

credit amount 0.25

credit type CME/CE

expiration 10/22/2020

Image Webcast
Trends in Infectious Diseases: Updates on Treatment & Prevention Strategies for HIV and HCV

Rapid Start ART — A New Model for HIV Care

Isolde Butler, MD, MPH; Charlene A. Flash, MD, MPH
MODULE 2
Begin Activity

credit amount 0.25

credit type CME/CE

expiration 10/22/2020

Image Webcast
Trends in Infectious Diseases: Updates on Treatment & Prevention Strategies for HIV and HCV

Understanding the Growing Syndemic —Opioids, HCV, and HIV

Don C. des Jarlais, PhD; Charlene A. Flash, MD, MPH
MODULE 3
Begin Activity

credit amount 0.25

credit type CME/CE

expiration 10/22/2020